A Clinical Trial of Ginseng in Diabetes
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Lyen an sove nan clipboard la
EstatiKonplete
Patwone
Washington University School of Medicine
ESÈ KLINIK: NCT00781534
BioSeek: nct00781534
Mo kle
Abstrè
a clinical study of Ginseng its potential affect on diabetes
Deskripsyon
Comparing three groups (those with & without normal blood sugar levels) to see if there is any clinically significant change in blood sugar levels in relationship to those taking:
1. ginseng
2. ginsenoside RE (a type of metabolized ginseng)
3. placebo
Dat
| Dènye verifye: | 08/31/2019 |
| Premye Soumèt: | 10/26/2008 |
| Enskripsyon Estimasyon Soumèt: | 10/26/2008 |
| Premye afiche: | 10/28/2008 |
| Dènye Mizajou Soumèt: | 09/04/2019 |
| Dènye Mizajou afiche: | 09/08/2019 |
| Dat aktyèl kòmanse etid la: | 08/31/2003 |
| Dat Estimasyon Prensipal Estimasyon an: | 11/30/2004 |
| Dat estime fini etid la: | 08/31/2008 |
Kondisyon oswa maladi
Diabetes
Entèvansyon / tretman
Drug: 1. Ginseng
Drug: 2. Ginsenosdie RE
Drug: 2. Ginsenosdie RE
Dietary Supplement: 3. Placebo
Faz
-
Gwoup bra
| Bra | Entèvansyon / tretman |
|---|---|
| Active Comparator: 1. Ginseng Ginseng group | Drug: 1. Ginseng Each of the 3 arms will be compared to determine if there is any clinical difference in blood sugars between the 3 groups |
| Active Comparator: 2. Ginsenosdie RE Ginsenoside RE (a metabolite of ginseng) group | Drug: 2. Ginsenosdie RE |
| Placebo Comparator: 3. Placebo placebo ("sugar" pill) group | Dietary Supplement: 3. Placebo placebo group |
Kritè kalifikasyon yo
| Laj ki kalifye pou etid | 18 Years Pou 18 Years |
| Sèks ki kalifye pou etid | All |
| Aksepte Volontè Healthy | Wi |
| Kritè | Inclusion Criteria: - ages 18-65 - healthy, non-diabetic - healthy, impaired glucose tolerance/mild diabetes (no medications required) Exclusion Criteria: - impaired glucose tolerance (borderline diabetes that requires medications) - diabetes (requiring medications) - caffeine sensitivity - known cardiac, peripheral vascular diseases - arrhythmias (irregular heart rhythms) |
